ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
97 hedge funds and large institutions have $49.7M invested in Endocyte, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
Holders
97
Holding in Top 10
–
Calls
$193K
Puts
$211K
Top Buyers
| 1 | +$563K | |
| 2 | +$348K | |
| 3 | +$222K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$211K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$183K |
Top Sellers
| 1 | -$1.5M | |
| 2 | -$611K | |
| 3 | -$489K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$376K |
| 5 |
HCM
Highbridge Capital Management
New York
|
-$347K |